Smokers should get pneumonia vaccine: U.S. advisers

WASHINGTON (Reuters) - Smokers should be vaccinated against a pneumonia-causing germ, along with children and the elderly, U.S. federal advisers recommended on Wednesday.

If accepted by the Centers for Disease Control and Prevention, it would be the first vaccine recommendation aimed specifically at smokers.

The vaccines, called pneumococcal vaccines, prevent infection with several strains of Streptococcus pneumonia, a bacteria that causes pneumonia, meningitis and other severe infections. They are routinely given to the elderly and to small children, but not to healthy young adults.

The Advisory Committee on Immunization Practices, meeting in Atlanta, had been asked to discuss whether the shot might benefit smokers, who have a higher risk of lung and respiratory infection in general.

“The ACIP voted to recommend smokers aged 19 through 64 years of age should be vaccinated with pneumococcal vaccine. The committee also recommended smokers who receive pneumococcal vaccine also undergo stop smoking counseling,” CDC spokesman Curtis Allen said by e-mail.

“This is the first time the ACIP has recommended a vaccine specifically for smokers.”

More than a fifth of U.S. adults smoke cigarettes, and the risk of pneumococcal disease rises with the number of cigarettes smoked over a lifetime. Smokers account for half of otherwise healthy adults with serious pneumococcal infections.

Several companies make pneumococcal vaccines.

Wyeth’s Prevnar vaccine protects against seven strains of Streptococcus pneumoniae and is a routine childhood vaccination, pulling in $2.5 billion a year for the company.  Continued…


Related Posts:

By Julie Steenhuysen CHICAGO (Reuters) - A routine childhood vaccine used to prevent several common types of infections has helped cut the rate of a deadly form of meningitis by 30 percent in children and adults, U.S. researchers said on Wednesday, suggesting even the unvaccinated are benefiting from the shot. They said the vaccine Prevnar made by

Full Post: Vaccine cuts meningitis rates, even in adults

NEW YORK (Reuters Health) - People with asthma are at increased risk of serious infection with pneumococcal bacteria, according to a new analysis of medical records. The findings, along with the high fatality rate from such infections, suggest that adults with asthma would benefit from the pneumococcal vaccine, Dr. Young J. Juhn of the Mayo Clinic

Full Post: Asthma may boost pneumococcal infection risk

By Megan Rauscher NEW YORK (Reuters Health) - Even in an influenza season where there is not an optimal match between circulating strains of influenza and the strains contained in the influenza vaccine, the vaccine is likely to significantly protect young children, ages 6 to 59 months, against influenza, new research indicates. Influenza vaccine effectiveness has not

Full Post: Influenza vaccine effective in young children

By Will Boggs, MD NEW YORK (Reuters Health) - Protection against hepatitis B appears to drop off in adolescents who got the hepatitis B vaccine beginning at birth, according to a new report. Dr. Stephanie R. Bialek from the US Centers for Disease Control and Prevention, Atlanta, Georgia, and colleagues evaluated the occurrence of breakthrough infections and

Full Post: Hepatitis B vaccine protection may wane in teens

By Will Dunham WASHINGTON (Reuters) - U.S. health officials asked doctors on Thursday to be alert for possible cases of meningitis and other illnesses in children caused by Hib bacteria amid an ongoing vaccine shortage. Officials are most concerned about bacterial meningitis and sepsis, a bloodstream infection, caused by Hib (Haemophilus influenzae type b) in children under

Full Post: Doctors to be on guard for meningitis in kids

Site Navigation

Most Read